Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

The SUMO protease SENP6 is a direct regulator of PML nuclear bodies.

Molecular biology of the cell - 1 Jan 2011

Hattersley Neil, Shen Linnan, Jaffray Ellis G, Hay Ronald T

Abstract excerpt

Promyelocytic leukemia protein (PML) is the core component of PML-nuclear bodies (PML NBs). The small ubiquitin-like modifier (SUMO) system (and, in particular, SUMOylation of PML) is a critical component in the formation and regulation of PML NBs. SUMO protease SENP6 has been shown previously to...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cysteine
Share to Cysteine Endopeptidases
Share to Fluorescent Antibody Technique

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Promyelocytic Leukemia Protein

Share to Protein Multimerization

Share to Protein Processing, Post-Translational

Share to Small Ubiquitin-Related Modifier Proteins

Share to Ubiquitination

Source

Open in PubMed Open full text

Identifiers

PMID: 21148299
DOI: 10.1091/mbc.E10-06-0504
PMCID: PMC3016979

Genes

PML
SENP6

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 4 Sept 2026. Prepared record publication-21148299-2026-09-04.2. Manifest publication-graph-cohort-2026-09-04.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 4 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

The SUMO protease SENP6 is a direct regulator of PML nuclear bodies.PMID 21148299Read ↗

The IL-6 family of cytokines modulates STAT3 activation by desumoylation of PML through SENP1 induction.Semantic proximity Read ↗

PML nuclear bodies: regulation, function and therapeutic perspectivesSemantic proximity Read ↗

Role of promyelocytic leukemia (PML) sumolation in nuclear body formation, 11S proteasome recruitment, and As2O3-induced PML or PML/retinoic acid receptor alpha degradation.Semantic proximity Read ↗

N4BP1 is a newly identified nucleolar protein that undergoes SUMO-regulated polyubiquitylation and proteasomal turnover at promyelocytic leukemia nuclear bodies.Semantic proximity Read ↗

Structure of the human SENP7 catalytic domain and poly-SUMO deconjugation activities for SENP6 and SENP7.Semantic proximity Read ↗

Interferon, restriction factors and SUMO pathwaysSemantic proximity Read ↗

SUMO-specific proteases/isopeptidases: SENPs and beyondSemantic proximity Read ↗

Pml Is Critical for Nd10 Formation and Recruits the Pml-Interacting Protein Daxx to This Nuclear Structure When Modified by Sumo-1Semantic proximity Read ↗

Sumoylation in Physiology, Pathology and TherapySemantic proximity Read ↗

SUMO : A new perspective to decipher fibrosisSemantic proximity Read ↗

Genetic alterations of the SUMO isopeptidase SENP6 drive lymphomagenesis and genetic instability in diffuse large B-cell lymphoma.Semantic proximity Read ↗

SUMO modification modulates the transrepression activity of PLZF.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.